Latest News and Press Releases

Toronto, Ontario, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Toronto, ON – [ Oct. 1, 2025 ] – Vielight Inc., a global leader in photobiomodulation (PBM) and neuro-stimulation technology, is excited to...

Toronto, Ontario, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Toronto, ON — Vielight Inc., a leader in photobiomodulation (PBM) technologies, is pleased to announce the issuance of a utility patent for its...

Toronto, Ontario, Sept. 02, 2025 (GLOBE NEWSWIRE) -- TORONTO — Aug. 28, 2025 — Vielight, the pioneers of brain photobiomodulation (PBM) neurotechnology, is rapidly emerging as a game-changer for...

TORONTO, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Vielight Inc., a global leader in brain health technology and photobiomodulation (PBM), proudly announces the launch of the Neuro Pro 2, its most advanced...

Toronto, Canada, July 26, 2023 (GLOBE NEWSWIRE) -- Vielight Inc. announced it has commenced a new clinical trial in the United States to study how brain stimulation photobiomodulation (PBM)...

Toronto, Canada, July 13, 2023 (GLOBE NEWSWIRE) -- The United States Patent and Trademark Office (USPTO) on April 25, 2023, granted a utility patent to Dr. Lew Lim for his invention, “System and...

Toronto, Canada, June 14, 2023 (GLOBE NEWSWIRE) -- Update to Release on Globe Newswire from May 25, 2023 13:30 ET Vielight announced on Thursday, May 25, 2023 that its Vielight RX Plus device -...

Toronto, Canada, March 29, 2022 (GLOBE NEWSWIRE) -- Vielight Inc., a global leader in transcranial photobiomodulation (tPBM) research, development and manufacturing, is pleased to announce a new...

Toronto, Canada, March 29, 2022 (GLOBE NEWSWIRE) -- Vielight Inc., a global leader in transcranial photobiomodulation (tPBM) research, development and manufacturing, is pleased to announce a new...

Toronto, Canada, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Vielight Inc. is pleased to announce the commencement of recruitment for a COVID-19 clinical trial in Ontario, Canada. This involves a home-use...